Advanced Targeted Drug Delivery for Colon Cancer Using Pristine and Surface-modified Hydroxyapatite Nanoparticles: Synthesis, Characterization, and pH-Responsive Release
Hydroxyapatite nanoparticles (HANs) have emerged as a promising candidate for targeted drug delivery in the treatment of colon cancer, a disease that remains one of the leading causes of cancer-related deaths globally. In this study, we synthesized and characterized HANs for their potential use as drug delivery vehicle for anticancer drugs specifically targeting colon cancer treatment. Through various in vitro assays, including drug loading efficiency, release kinetics, we demonstrated that HANs exhibit efficient drug loading capacity, and sustained release behavior, which could collectively contribute to enhanced therapeutic outcomes against colon cancer cells. The findings highlight the potential of HANs to serve as a versatile platform for the targeted drug delivery of chemotherapeutic agents, offering a novel approach that could improve treatment efficacy while minimizing side effects due to biocompatibility of the particles. Future research should focus on in vivo studies and clinical translation to further validate the potential of HANs in cancer therapy as drug carrier.
Code (0)
등록된 구현이 없습니다.
Methods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Mesoporous Silica Nanoparticles-based Smart Nanocarriers for Targeted Drug Delivery in Colorectal Cancer Therapy
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for advanced therapeutic strategies. Nanoparticle-based drug delivery systems have emerged as a promisin…
SpecificitySimulation of Nanorobots with Artificial Intelligence and Reinforcement Learning for Advanced Cancer Cell Detection and Tracking
Nanorobots are a promising development in targeted drug delivery and the treatment of neurological disorders, with potential for crossing the blood-brain barrier (BBB). These small devices leverage advancements in nanote…
Cell DetectionNavigateQ-LearningReinforcement Learning (RL)Advances in Nanoparticle-Based Targeted Drug Delivery Systems for Colorectal Cancer Therapy: A Review
Colorectal cancer (CRC) continues to be a significant global health burden, prompting the need for more effective and targeted therapeutic strategies. Nanoparticle-based drug delivery systems have emerged as a promising …
SpecificityUtilizing Differential Evolution into optimizing targeted cancer treatments
Working towards the development of an evolvable cancer treatment simulator, the investigation of Differential Evolution was considered, motivated by the high efficiency of variations of this technique in real-valued prob…
AttributeDiversityTargeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown
A tri-block nanoparticle (TBN) comprising of an enzymatically cleavable porous gelatin nanocore encapsulated with gefitinib (tyrosine kinase inhibitor (TKI)) and surface functionalized with cetuximab-siRNA conjugate has …